Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.
AllAfrica on MSN
Two Drugmakers Will Sell The 6-monthly Anti-HIV Jab for The Price of The Daily HIV Prevention Pill
Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...
A study links lower levels of the inhibitory neurotransmitter GABA to neuropathic pain in people with HIV, offering insight into potential pain mechanisms.
A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention programme ...
Scientists have long studied how Zika virus harms the developing brain, but until now, its effects on the adult brain were less clear ...
Learn about the unique health and social needs of HIV-infected senior Americans. Health experts emphasize the importance of prevention, testing, and care.
That led to a lifelong struggles with severe joint damage, atrophied legs and a diagnosis of HIV after a blood transfusion. Medical treatment allowed him to stop using a wheelchair at 16, but he still ...
Thornton, an Emmy Award-winning AIDS activist and 40-year survivor, shares her story of living with HIV/AIDS and warns that secrecy can be deadly, urging people to get tested and take responsibility ...
Without clear timelines and accountability, Ireland risks falling short of its goal to end new HIV transmissions by 2030.
A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...
Tarava’s story illustrates the remarkable progress Zimbabwe has made in tackling the HIV crisis. Once ravaged by soaring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results